Allogene Therapeutics, Inc.
Total Trades
35
Buys
2
Sells
33
Largest Trade
$1M+
Insiders
16
Institutional Funds
134
Inst. Value
$1M+
Activist Filings
39
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Beneski Benjamin Machinas | SVP | SELL | $15K–$50K | 7K | $2.60 | Mar 4, 2026 |
| Beneski Benjamin Machinas | SVP | SELL | $1K–$15K | 8K | $1.73 | Feb 4, 2026 |
| Chang David D | President and CEO | SELL | $100K–$500K | 95K | $1.80 | Feb 4, 2026 |
| Parker Geoffrey M. | CHIEF FINANCIAL OF… | SELL | $15K–$50K | 24K | $1.76 | Feb 4, 2026 |
| Douglas Earl Martin | SVP, General Counsel | SELL | $15K–$50K | 23K | $1.76 | Feb 4, 2026 |
| Yoshiyama Annie | SVP, Finance | SELL | $1K–$15K | 4K | $1.72 | Feb 4, 2026 |
| Roberts Zachary | EVP of R&D | SELL | $50K–$100K | 36K | $1.77 | Feb 4, 2026 |
| Roberts Zachary | EVP of R&D | SELL | $15K–$50K | 26K | $1.56 | Jan 23, 2026 |
| Beneski Benjamin Machinas | SVP | SELL | <$1K | 786 | $1.22 | Nov 19, 2025 |
| Parker Geoffrey M. | CHIEF FINANCIAL OF… | SELL | $15K–$50K | 37K | $1.26 | Oct 23, 2025 |
| MESSEMER DEBORAH M. | Director | SELL | $50K–$100K | 37K | $1.42 | Jun 12, 2025 |
| Yoshiyama Annie | SVP, Finance | SELL | $1K–$15K | 10K | $1.41 | Apr 23, 2025 |
| Chang David D | President and CEO | SELL | $50K–$100K | 47K | $1.96 | Mar 18, 2025 |
| Beneski Benjamin Machinas | SVP | SELL | $1K–$15K | 5K | $1.98 | Mar 18, 2025 |
| Roberts Zachary | EVP of R&D | SELL | $15K–$50K | 27K | $1.78 | Jan 23, 2025 |
| MESSEMER DEBORAH M. | Director | SELL | $15K–$50K | 19K | $2.28 | Jun 20, 2024 |
| Humer Franz B | Director | SELL | $15K–$50K | 11K | $2.34 | Jun 3, 2024 |
| Mayo Stephen | Director | SELL | $15K–$50K | 10K | $4.29 | Aug 9, 2023 |
| Bhavnagri Veer | General Counsel | SELL | $15K–$50K | 3K | $6.85 | Feb 14, 2023 |
| Bhavnagri Veer | General Counsel | SELL | $15K–$50K | 3K | $7.04 | Jan 18, 2023 |
| Bhavnagri Veer | General Counsel | SELL | $15K–$50K | 6K | $7.53 | Dec 19, 2022 |
| WITTE OWEN N. | Director | SELL | $100K–$500K | 15K | $16.75 | Aug 15, 2022 |
| WITTE OWEN N. | Director | SELL | $100K–$500K | 15K | $16.75 | Aug 15, 2022 |
| Amado Rafael | EVP of R&D and CMO | SELL | $15K–$50K | 2K | $11.97 | Aug 2, 2022 |
| Amado Rafael | EVP of R&D and CMO | SELL | $15K–$50K | 2K | $11.44 | Jul 6, 2022 |
| WITTE OWEN N. | Director | SELL | $100K–$500K | 10K | $11.76 | Jun 23, 2022 |
| Amado Rafael | EVP of R&D and CMO | SELL | $15K–$50K | 2K | $11.18 | Jun 22, 2022 |
| Amado Rafael | EVP of R&D and CMO | SELL | $50K–$100K | 12K | $7.40 | May 19, 2022 |
| Amado Rafael | EVP of R&D and CMO | SELL | $15K–$50K | 5K | $7.71 | Mar 17, 2022 |
| Bhavnagri Veer | General Counsel | SELL | $50K–$100K | 9K | $7.68 | Mar 17, 2022 |
| Chang David D | President and CEO | SELL | $100K–$500K | 24K | $7.65 | Mar 17, 2022 |
| SCHMIDT ERIC THOMAS | CFO | SELL | $50K–$100K | 11K | $7.63 | Mar 17, 2022 |
| MOORE ALISON | Chief Technical Of… | SELL | $50K–$100K | 9K | $7.63 | Mar 17, 2022 |
| Kazam Joshua A | Director | BUY | $100K–$500K | 15K | $12.60 | Jan 14, 2022 |
| Belldegrun Arie | Director | BUY | $1M+ | 155K | $12.60 | Jan 14, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 134 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| PFIZER INC | 22.0M | $1M+ | SH |
| TPG GP A, LLC | 18.7M | $1M+ | SH |
| VANGUARD GROUP INC | 8.2M | $1M+ | SH |
| PRIMECAP MANAGEMENT CO/CA/ | 8.1M | $1M+ | SH |
| Patient Square Capital LP | 5.0M | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 3.9M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 3.4M | $1M+ | SH |
| Wildcat Capital Management, LLC | 2.9M | $1M+ | SH |
| STATE STREET CORP | 2.8M | $1M+ | SH |
| Kalehua Capital Management LLC | 2.5M | $1M+ | SH |
| Candriam S.C.A. | 2.3M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 2.2M | $1M+ | SH |
| Aberdeen Group plc | 2.1M | $1M+ | SH |
| JANE STREET GROUP, LLC | 1.6M | $1M+ | SH |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 22K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.4M | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 995K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 900K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 860K | $1M+ | SH |
| BARCLAYS PLC | 636K | $500K+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Feb 13, 2026
9.0%
22.0M shares
SC 13G · Feb 13, 2026
5.2%
12.1M shares
SC 13G/A · Nov 14, 2025
5.6%
12.7M shares
SC 13G/A · Nov 14, 2025
0.0%
0 shares
SC 13G/A · Nov 12, 2025
4.9%
11.2M shares
SC 13G/A · Aug 12, 2025
5.7%
12.6M shares
SC 13G/A · Aug 9, 2025
5.0%
11.1M shares
SC 13G · Jul 16, 2025
4.7%
10.2M shares
SC 13G · May 13, 2025
5.6%
12.3M shares
SC 13G/A · May 9, 2025
5.0%
11.0M shares
SC 13G/A · May 9, 2025
5.7%
12.5M shares
SC 13G/A · Apr 17, 2025
5.3%
11.5M shares
SC 13G/A · Mar 7, 2025
4.9%
10.2M shares
SC 13G · Feb 14, 2025
5.2%
10.9M shares
SC 13G/A · Feb 13, 2025
5.8%
12.4M shares
SC 13G/A · Feb 13, 2025
5.1%
10.9M shares
SC 13G/A · Feb 12, 2025
11.3%
23.8M shares
SC 13G/A · Nov 12, 2024
4.0%
8.3M shares
SC 13G/A · Nov 8, 2024
8.5%
17.8M shares
SC 13G · Nov 4, 2024
4.0%
8.3M shares
SC 13G/A · Oct 22, 2024
8.5%
17.8M shares
SC 13G/A · Feb 14, 2024
5.8%
9.9M shares
SC 13G/A · Feb 14, 2024
5.8%
10.0M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
5.4%
9.0M shares
SC 13G/A · Jan 29, 2024
5.9%
10.0M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 23, 2024
1.4%
0 shares
SC 13D/A · Oct 25, 2023
13.1%
22.0M shares
SC 13G · Jul 10, 2023
17.1%
24.9M shares
SC 13G · Feb 13, 2023
5.7%
8.4M shares
SC 13G/A · Feb 13, 2023
6.1%
8.9M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G · Feb 3, 2023
6.4%
0 shares
SC 13G · Feb 3, 2023
6.2%
8.9M shares
SC 13D/A · Apr 7, 2022
15.4%
22.0M shares
SC 13G/A · Feb 14, 2022
4.9%
7.0M shares
SC 13G/A · Feb 14, 2022
5.0%
7.2M shares
Capital Research Global Investors 95-1411037
SC 13G/A · Feb 11, 2022
0.0%
0 shares
Capital International Investors 95-1411037
SC 13G/A · Feb 11, 2022
1.2%
1.7M shares
SC 13G/A · Feb 10, 2022
0.8%
1.2M shares
SC 13D/A · Jan 18, 2022
13.2%
18.7M shares